Celgene Launches Celgene Cancer Care Links TM to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries
December 05 2017 - 7:30AM
Business Wire
Grant Program Will Help Fund Cancer Care
Capability, Delivery and Access Programs
Celgene Corporation (NASDAQ:CELG) today announced the launch of
Celgene Cancer Care Links, a new grant program designed to support
cancer healthcare capacity building in resource-constrained
countries around the world. As part of this program, Celgene will
collaborate with medical centers focused on enhancing patient care
and building sustainable cancer care systems in
resource-constrained countries. Funding will be provided to
approved programs in 2018.
“Celgene’s purpose is to change the course of human health
through bold pursuits in science, and promise to always put
patients first,” said Mark J. Alles, Chief Executive Officer at
Celgene. “As an extension of that purpose, our hope is that Celgene
Cancer Care Links will support improved cancer care in some of the
world’s underserved areas.”
Applications will be accepted for programs to support medical
centers in resource-constrained countries around the world that
provide essential cancer care services, including oncology
training, cancer prevention and detection, nursing programs,
general medical support, pharmacy programs, and awareness and
education initiatives. Interested organizations can visit
http://www.celgene.com/responsibility/global-health/celgene-cancer-care-links/
for more information about the application process.
“Celgene Cancer Care Links aims to build capacity within cancer
centers to better manage prevention, early diagnosis, and treatment
to improve patient lives,” said Joe Camardo, MD, Senior Vice
President, Global Health and Corporate Affairs Medical Strategy at
Celgene.
Celgene Cancer Care Links is the latest addition to Celgene’s
global health and corporate responsibility initiatives. For
additional information on Celgene’s work in global health, visit
http://www.celgene.com/responsibility/global-health/. Celgene
Cancer Care Links also supports Celgene’s commitment to Access
Accelerated, a partnership of over 20 biopharmaceutical companies
developing innovative and sustainable solutions to improve access
to non-communicable disease treatment and care in low and
middle-income countries.
About Celgene Cancer Care Links
Celgene Cancer Care Links is a grant program to support health
care capacity initiatives that enhance patient cancer care in
resource-constrained countries. Celgene Cancer Care Links is a
demonstration of Celgene’s commitment to improving the lives of
patients worldwide. For more information visit
http://www.celgene.com/responsibility/global-health/celgene-cancer-care-links/.
About Access Accelerated
Access Accelerated is a partnership of over 20 biopharmaceutical
companies working together to develop innovative and sustainable
solutions to improve access to non-communicable disease treatment
and care in low and middle-income countries. In addition to each
company committing to do more with their individual programs,
Access Accelerated also includes partnerships with the World Bank
and the Union of International Cancer Control. Access Accelerated
is part of the private sector’s commitment to achieving the United
Nations Sustainable Development Goal target to reduce premature
deaths from NCDs by 2030. More information at
www.AccessAccelerated.org.
About Celgene
Celgene Corporation, headquartered in Summit, New
Jersey, is an integrated global biopharmaceutical company engaged
primarily in the discovery, development and commercialization of
innovative therapies for the treatment of cancer and inflammatory
diseases through next-generation solutions in protein homeostasis,
immuno-oncology, epigenetics, immunology and neuro-inflammation.
For more information, please visit www.celgene.com. Follow
Celgene on social media:
@Celgene, Pinterest, Facebook and YouTube.
Forward-Looking Statements
This press release contains forward-looking statements, which
are generally statements that are not historical facts.
Forward-looking statements can be identified by the words
"expects," "anticipates," "believes," "intends," "estimates,"
"plans," "will," “outlook” and similar expressions. Forward-looking
statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. We undertake no obligation to update any forward-looking
statement in light of new information or future events, except as
otherwise required by law. Forward-looking statements involve
inherent risks and uncertainties, most of which are difficult to
predict and are generally beyond our control. Actual results or
outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual
Report on Form 10-K and our other reports filed with the Securities
and Exchange Commission.
Hyperlinks are provided as a convenience and for informational
purposes only. Celgene bears responsibility for the security or
content of external websites or websites outside of its
control.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171205005734/en/
CelgeneMedia:+1-908-673-2275media@celgene.com
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Apr 2023 to Apr 2024